中国医生为世界心血管外科“极难手术”提供新方案

2020-07-04 中国新闻网 中国新闻网

柳克祥(左三)正在为病人会诊。吉林大学第二医院供图

中国医生为世界心血管外科“最难手术”提供新方案

柳克祥(左三)正在为病人会诊。吉林大学第二医院供图

中新网长春7月2日电 (记者 郭佳)记者2日从吉林大学第二医院获悉,该院柳克祥教授团队为心血管外科领域最难的手术之一——A型主动脉夹层动脉瘤手术提供了新方案。

今年5月,柳克祥团队“新颖的内覆式主动脉弓部置换手术法治疗A型主动脉夹层动脉瘤”一文发表在外科领域国际最顶级医学学术期刊《外科学年鉴》(Annals of Surgery)上。

吉林大学第二医院副院长柳克祥表示,A型主动脉夹层动脉瘤是目前临床上发病急、致死率最高的疾病,国际上通常采用外科手术进行治疗,是心血管外科领域公认的“最难手术”之一。

柳克祥介绍,该团队发明的新手术方法——新颖的内覆式主动脉弓部置换手术法,相对世界上通常采用的方法,操作简单,容易掌握;降低了手术并发症发生率,提高了手术成功率。

柳克祥表示,在手术时间上,由传统的至少7小时以上减少到5小时,同时,由于吻合口少也减少了出血,解决了术中需要大量输血的问题。

柳克祥是中国医师协会心血管外科分会“金刀奖”获得者,十余年间,他带队先后发明了8个新手术方法,帮助该院在冠脉搭桥和大血管领域达到国际领先水平。

《外科学年鉴》是美国外科协会、欧洲外科协会、纽约外科学会和费城外科学会的官方杂志,创刊于1885年,是外科学界最早诞生的官方杂志,影响因子=10.13,是中科院一区Top期刊。(完)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=891378, encodeId=cc308913e8a2, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/dbb5a26e62614536819f04769a918373/aaaa581a1bad48438359ebf0427bfea2.jpg, createdBy=cb855425012, createdName=胰生肝, createdTime=Mon Oct 12 07:57:35 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649254, encodeId=42cc164925424, content=<a href='/topic/show?id=3ecd51e8949' target=_blank style='color:#2F92EE;'>#心血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51789, encryptionId=3ecd51e8949, topicName=心血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=992e23785444, createdName=luoxiaog, createdTime=Tue Jun 15 22:09:24 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423477, encodeId=fea414234e738, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526962, encodeId=4c7d1526962eb, content=<a href='/topic/show?id=894221e3566' target=_blank style='color:#2F92EE;'>#中国医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21735, encryptionId=894221e3566, topicName=中国医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f511780919, createdName=nakerunner, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=)]
    2020-10-12 胰生肝

    厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=891378, encodeId=cc308913e8a2, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/dbb5a26e62614536819f04769a918373/aaaa581a1bad48438359ebf0427bfea2.jpg, createdBy=cb855425012, createdName=胰生肝, createdTime=Mon Oct 12 07:57:35 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649254, encodeId=42cc164925424, content=<a href='/topic/show?id=3ecd51e8949' target=_blank style='color:#2F92EE;'>#心血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51789, encryptionId=3ecd51e8949, topicName=心血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=992e23785444, createdName=luoxiaog, createdTime=Tue Jun 15 22:09:24 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423477, encodeId=fea414234e738, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526962, encodeId=4c7d1526962eb, content=<a href='/topic/show?id=894221e3566' target=_blank style='color:#2F92EE;'>#中国医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21735, encryptionId=894221e3566, topicName=中国医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f511780919, createdName=nakerunner, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=891378, encodeId=cc308913e8a2, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/dbb5a26e62614536819f04769a918373/aaaa581a1bad48438359ebf0427bfea2.jpg, createdBy=cb855425012, createdName=胰生肝, createdTime=Mon Oct 12 07:57:35 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649254, encodeId=42cc164925424, content=<a href='/topic/show?id=3ecd51e8949' target=_blank style='color:#2F92EE;'>#心血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51789, encryptionId=3ecd51e8949, topicName=心血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=992e23785444, createdName=luoxiaog, createdTime=Tue Jun 15 22:09:24 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423477, encodeId=fea414234e738, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526962, encodeId=4c7d1526962eb, content=<a href='/topic/show?id=894221e3566' target=_blank style='color:#2F92EE;'>#中国医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21735, encryptionId=894221e3566, topicName=中国医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f511780919, createdName=nakerunner, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=891378, encodeId=cc308913e8a2, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/dbb5a26e62614536819f04769a918373/aaaa581a1bad48438359ebf0427bfea2.jpg, createdBy=cb855425012, createdName=胰生肝, createdTime=Mon Oct 12 07:57:35 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649254, encodeId=42cc164925424, content=<a href='/topic/show?id=3ecd51e8949' target=_blank style='color:#2F92EE;'>#心血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51789, encryptionId=3ecd51e8949, topicName=心血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=992e23785444, createdName=luoxiaog, createdTime=Tue Jun 15 22:09:24 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423477, encodeId=fea414234e738, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526962, encodeId=4c7d1526962eb, content=<a href='/topic/show?id=894221e3566' target=_blank style='color:#2F92EE;'>#中国医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21735, encryptionId=894221e3566, topicName=中国医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f511780919, createdName=nakerunner, createdTime=Mon Jul 06 09:09:24 CST 2020, time=2020-07-06, status=1, ipAttribution=)]

相关资讯

JACC:他汀可能降低健康老年人残疾和心血管疾病风险

对于年龄≥70岁的健康受试者,他汀类药物的益处和危害存在临床不确定性。这项研究的目的是在健康老年人中研究他汀类药物、无痴呆症和无残疾生存率以及心血管疾病(CVD)之间的关系。

Eur Heart J:他汀类药物可明显增加血浆脂蛋白a的水平

脂蛋白(a)[LP(a)]在20%-30%的人群中都存在升高,本研究的目的旨在评估他汀类药物治疗对脂蛋白(a)水平的影响。

PeerJ:颈动脉内-中膜厚度与突发感音神经性耳聋相关性研究

心血管因素与突发感音神经性耳聋(SSNHL)的病理生理特性和风险存在相关性。然而,关于颈动脉内-中膜厚度(IMT)与SSNHL风险和各自的治疗结果之间的关系仍旧了解很少。

JAHA:心脏无创诊断试在门诊心绞痛患者的应用

尽管在美国,每年对稳定的冠状动脉疾病进行的心脏无创诊断试验(NIT)超过400万次,目前尚不清楚与无检测相比,它们是否与预后的改善有关。本研究的目的旨在评估NIT是否与预后的改善相关。

Eur Heart J:血浆甘油三酯升高可增加主动脉瓣狭窄发生风险

本研究的目的旨在验证血浆甘油三酯和残余胆固醇水平的升高与主动脉瓣狭窄风险的增加有关。

JACC:压力反射疗法可明显改善心衰患者生活质量

本研究旨在证明压力反射激活疗法(BAT)对射血分数降低的心力衰竭患者(HFrEF)的安全性和有效性。